Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma
Status:
RECRUITING
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
This clinical study aims to learn about the efficacy and safety of aspirin continuation or discontinuation in conservative treatment for chronic subdural hematoma. All participants received standard conservative treatment for chronic subdural hematoma, with a randomized intervention to either continue or discontinue aspirin administration. By participating in this study, participants can receive additional scientific guidance on aspirin medication management beyond routine conservative treatment, thereby optimizing individualized therapy.
Phase:
NA
Details
Lead Sponsor:
Tao Liu
Collaborators:
Tianjin Medical University General Hospital Xuanwu Hospital, Beijing